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The 3% of UKR performed in young males (age<60) weighing 180lb or over with high activity 23 levels, who have been reported to have poor outcomes after fixed-bearing UKR, had 24 significantly better AKSS-F (p<0.001), OKS (p=0.01) and Tegner Activity Score (p<0.001) at 25 ten-years. No difference in AKSS-O (p=0.54) at ten-years or implant survival at fifteen-years 26 (p=0.75) was seen. 27
Conclusion: 28

Introduction 35
Unicompartmental knee replacement (UKR) has significant patient benefits over total knee 36 replacement (TKR) including improved functional outcomes and significantly lower morbidity 37 and mortality [1] . Despite the benefits of UKR it remains relatively underutilised and this in part 38 is due to controversies in the indications. In their seminal paper on UKR Kozinn and Scott 39 highlighted the benefits of UKR including retained normal knee kinematics and proprioception, 40 improved range of movement, preserved bone stock and, in the case of failure, ability to revise 41 to a primary TKR [2] . However to optimise outcomes, primarily based on their experience with 42 a fixed-bearing device, they advised strict patient and disease criteria for the procedure [2] . 43
The Oxford UKR (Zimmer Biomet, Warsaw, Indiana, USA) employs a fully congruous freely 44 mobile-bearing articulating with a spherical femur and a flat tibia. In contrast to the indications 45
proposed by Kozinn and Scott, the indications used for the Oxford UKR lie solely with the 46 pathoanatomy of the disease [3] . The Oxford medial UKR is indicated for the treatment of 47 anteromedial osteoarthritis (AMOA) and spontaneous osteonecrosis of the knee (SONK) [3] . 48
In AMOA there should be 1) bone-on-bone arthritis in the medial compartment 2) retained full 49 thickness cartilage in the lateral compartment, best visualised on a valgus stress X-ray 3) a 50 functionally normal medial collateral ligament (MCL) and 4) a functionally normal anterior 51 cruciate ligament (ACL) [4] . The status of the patellofemoral joint (PFJ), with the exception of 52 bone loss with grooving laterally, is not considered a contra-indication to Oxford UKR. 53
When the contra-indications to UKR as proposed by Kozinn and Scott are applied to the knee 54 replacement population it has been reported that around 6% of patients may be considered 55 appropriate for UKR, whereas using the criteria for Oxford UKR up to half of patients may be 56 eligible [5, 6] . 57
In a recent publication we have demonstrated a survival of 91% at 15years with 81% of 58 patients achieving good or excellent functional outcomes as assessed by AKSS at ten-years 59 following UKR using the indications for Oxford UKR, which in our practice is satisfied in over 60 50% of cases needing knee replacement [7] . The primary purpose of this study is to investigate 61 whether applying previously published contra-indications as advised by Kozinn and Scott and 62 others influences fifteen-year survival and ten-year functional outcomes in 1000 consecutive 63 cemented mobile-bearing UKRs. The secondary purpose is to perform subgroup analysis to 64 assess the outcomes of mobile-bearing UKR performed in young, heavy, highly active males, 65 who have been reported to have poor outcomes after fixed-bearing UKR [8] . 66
Patients and Methods 68
Details of this cohort have been published previously [7] . In summary, between June 1998 and 69
March 2009 1000 consecutive Oxford UKRs were performed in 818 patients via a minimally 70 invasive approach by two designer surgeons (DWM & CAFD) with all patients meeting the 71 recommended indications for UKR as described by Goodfellow et al. [3] . The mean age at the 72 time of operation was 66 (range 32 to 88) with 48% of the patients being male (393 patients) 73 and 52% female (425 patients). 74
Outcome assessments were performed by a research physiotherapist independent of the 75 clinical team using a standard protocol of clinical review with functional assessment pre-76 operatively and at one, five, seven, ten, twelve and fifteen-years. Functional outcomes were 77 assessed using the: AKSS-O, AKSS-F, OKS, and Tegner Activity Score [9] [10] [11] . In addition the 78 AKSS-O was calculated without performing deductions for alignment, as unlike TKR, the 79
Oxford UKR aims to restore pre-disease alignment not achieve neutral alignment [12] . All 80 patients, with the exception of four lost to follow up in the first year, were contacted in the 81 previous 18months to ascertain the current functional status of their knee and incidence of re-82 operations. Where patients had died, information about the status of their knee and further 83 operations was obtained from primary and secondary care records as well as the patient's 84 relatives where appropriate. Any complications and reoperations were carefully recorded and 85
analysed. 86
Patients were classified into subgroups based on each of the previously proposed contra-87 indications to UKR: younger than 60years, weight 180lb (82kg) or more, high levels of activity, 88 chondrocalcinosis and exposed bone in the PFJ. High activity level was classified as a Tegner 89 activity score of 5 or above at any stage after surgery as this incorporates: heavy labour (e.g. 90 building/forestry) and/or competitive sports (e.g. cycling/cross-country skiing) and/or 91 recreational sports (jogging on uneven ground at least twice a week). 92
This study was approved by the local ethics committee who confirmed that the clinical follow 93 up formed part of routine assessment and therefore does not need formal ethical approval. 94
Consent was taken from all patients for involvement in this study including consent to use data 95 from medical records and radiographs. 96
Statistical Analysis 98
A power calculation was performed using the minimally clinically important difference reported 99 for OKS [13] . Using the Altman nomogram for a power of 80% at a significance level of 0.05 100 and using a standard deviation of 8, a sample size of 80 patients is required to detect a 101 clinically important difference between groups. Due to differences in the number of knees in 102 each group, with knees with reported contraindications typically having fewer knees than those 103 without, it was established that a minimum of 20 knees in the smaller cohort was required to 104 for the study to have adequate power [14] . 105
Functional outcomes and implant survival were compared between groups based on whether 106 patients had any, or none, of the published contra-indications, and on the presence, or 107 absence, of each of the individual published contra-indications. An additional subgroup of 108 young males (age<60) weighing 180lb or more with a high activity level, who have been 109
reported to have poor outcomes after fixed-bearing UKR, was compared to the outcomes of 110 knees not in this group. 111
Functional outcomes were compared at 10years using non-parametric tests (Kruskal-Wallis). 112
Differences in categorical functional outcomes were assessed using a Ch-Squared test. 113
Survival was assessed using life-table analysis with confidence intervals (CI) calculated using 114 the method described by Peto et al. [15] . Survival was compared using the log-rank test. A 115 broad definition of failure was used with failure defined as any implant-related re-operation, 116 which included any re-operations in which components were removed, changed, in which the 117 mobile-bearings were replaced for dislocation, and any re-operations in which new 118 components were inserted. Statistical significance was defined as p<0.05. 119
Results 121
The mean follow up was 10.3years (range 5.3 to 16.6) with 516 knees having a minimum ten-122 year follow up and 60 knees a minimum fifteen-year follow-up. All patients were followed up 123 for a minimum of five-years with the exception of those who were lost to follow up (4), died 124 (44), underwent revision (23) or withdrew from the study due to poor health (10) . In all patients 125 that died the status of the implant at death was known. None of the patients who withdrew 126 from the study had revisions. 127
Overall 81% of knees in this cohort, 86% without deductions for alignment, achieved good or 128 excellent outcomes using AKSS-O criteria at ten-years with a fifteen-year survival of 91% 129 (95%CI, 83 -98%) [7] . 130
Contra-indicated vs ideal 131
Over two-thirds of knees (68%, 678knees) were considered contra-indicated for UKR based 132 on the previously reported contraindications of: age under 60years, weight 180lb or over, high 133 activity levels, chondrocalcinosis, and evidence of exposed bone in the PFJ. Pre-operatively 134 no difference in AKSS-O (p=0.79), AKSS-F (p=0.15), OKS (p=0.86) was seen between contra-135 indicated and ideal knees with contra-indicated knees having higher Tegner Activity scores 136 (p=0.01). 137
At ten-years no difference in AKSS-O or OKS was detected between contra-indicated and 138 ideal knees, however contra-indicated knees had significantly better AKSS-F and Tegner 139
Activity scores than ideal knees. Table 1 . Figure 1 & 2. At ten-years, 7% of contra-indicated 140 knees had poor outcomes (AKSS-O <60) whereas 18% of ideal knees had poor outcomes. 141
The difference was statistically significant (p=0.02). Figure 3A . No difference in time to failure, mechanism of failure or implant survival was found between 152 contra-indicated and ideal knees at fifteen-years. Table 1 . Figure 4 . 153
Effect of age 154
A quarter of the UKR in this series (25%, 245knees) were implanted in patients aged under 155 60years, with this group having a mean age of 54years (range 33 to 60). Pre-operatively no 156 difference in AKSS-O (p=0.31), AKSS-F (p=0.07), OKS (p=0.47) or Tegner Activity score 157 (p=0.07) was seen between those aged under 60 and those aged 60 years and older. 158
At ten-year follow up patients aged under 60years at the time of operation had significantly 159 better AKSS-F, OKS and Tegner Activity scores than those patients who did not meet these 160 criteria. Table 1 Table 1 . 166
Effect of weight 167
Almost half of the UKR in this series (45%, 449knees) were implanted in patients who 168 weighted 180lb or greater. The mean weight in this group was 209lb (range 180 to 408). Pre-169 operatively no difference in AKSS-O (p=0.73), AKSS-F (p=0.12) or OKS (p=0.74) was seen 170 between groups with the pre-operative Tegner Activity Scale was found to be significantly 171 higher in those who weighed 180lb or greater (p=0.01). 172
At ten-year follow up no difference in AKSS-O, AKSS-F or OKS was seen between those who 173 weighed 180lb or greater and those that did not with Tegner Activity scores remaining higher 174 in those than those patients who weighed 180lb or greater. 
Effect of activity level 182
Ten percent of the UKR in this series (96knees) were implanted in patients who reported high 183 activity, a Tegner Activity Score of ≥5, post-operatively. The mean Tegner Activity Score in 184 the high activity group was 5.4 (range 5 to 8) with pre-operatively the high activity group 185 reporting significantly higher AKSS-F (p<0.001), OKS (p=0.02) and Tegner Activity scores 186 (p<0.001) with no difference in AKSS-O (p=0.34) between groups detected. 187
At ten-year follow up the high activity group had better AKSS-F, OKS and Tegner Activity 188 scores, however no difference in AKSS-O scores were seen compared to those patients that 189 did not report high activity. No difference in time to failure, mechanism of failure, or fifteen-year implant survival was seen 194 between groups. Table 1 . 195
Effect of chondrocalcinosis 196
Thirteen percent of the UKR in this series (126knees) were implanted in patients with evidence 197 of chondrocalcinosis. Pre-operatively no difference in AKSS-O (p=0.12), AKSS-F (p=0.11) or 198 OKS (p=0.69) was seen between those knees with or without chondrocalcinosis however 199 those with chondrocalcinosis reported worse Tegner Activity scores (p=0.03). 200
At ten-year follow up no difference in activity scores was seen between groups with no 201 difference in categorical functional outcomes seen (p=0.46). Table 1 . In knees with 202 chondrocalcinosis 83% (90% excluding deductions for alignment) achieved good or excellent 203 results, compared to 81% (86% excluding deductions for alignment) of knees without 204
chondrocalcinosis. 205
No difference in time to failure, mechanism of failure, or fifteen-year implant survival was seen 206 between groups. Table 1 . 207
Effect of patellofemoral joint disease 208
Sixteen percent of the UKR in this series (158knees) were implanted in patients with exposed 209 bone in the PFJ. Pre-operatively no difference in AKSS-O (p=0.51), AKSS-F (p=0.38), OKS 210 (p=0.26) or Tegner Activity scores (p=0.86) was seen between those knees with exposed 211 bone and those without. 212
At ten-year follow up no difference in outcome scores or in categorical functional outcomes 213 was seen between those knees with exposed bone at the PFJ and those without (p=0.38). 214 Table 1 . In knees with exposed bone in the PFJ 85% (88% excluding deductions for alignment) 215 obtained good or excellent results, compared to 81% (86% excluding deductions for 216 alignment) of knees without exposed bone at the PFJ. 217
No difference in time to failure, mechanism of failure, or fifteen-year implant survival was seen 218 between groups. Table 1 . 219
Compound Assessment: Young males (age<60) weighing 180lb or more with high 220
activity levels 221
Three percent of UKR in this series (28knees) were performed in young males (age<60) 222 weighing 180lb or more with high activity levels. Pre-operatively this group reported higher 223 AKSS-F (p=0.02), OKS (p=0.003) and Tegner Activity scores (p<0.001) than knees not in this 224 group with no difference in AKSS-O (p=0.06). 225
At ten-years young males weighing more than 180lb with high activity level reported 226 significantly (p<0.001) higher AKSS-F, OKS and Tegner Activity scores compared to knees 227 not in this group with no difference in AKSS-O. Table 1 . No difference in categorical functional 228 outcomes was seen at ten-years between groups (p=0.22) with 89% (94% excluding 229 deductions for alignment) of knees in young males weighing more than 180lb with high activity 230 level obtaining good or excellent results, compared to 81% (85% excluding deductions for 231 alignment) of knees not in this group. 232
No difference in time to failure, mechanism of failure, or fifteen-year implant survival was seen 233 between groups. Table 1 . 234
Discussion 237
Overall 68% (678) of knees had one or more contraindication to UKR according to the 238 previously published literature with this study finding no evidence that these published 239 contraindications should be applied to mobile-bearing UKR. At ten-year follow up, 85% of 240 knees (87% without deductions for alignment) that would be considered contraindicated for 241 UKR had good or excellent outcomes using AKSS-O criteria. This contra-indicated group 242 reported significantly better AKSS-F and OKS scores compared to those knees considered 243 ideal candidates and had significantly fewer poor results. Additionally no difference in time to 244 failure, mechanism of failure, or implant survival at fifteen-years was observed between the 245
groups. 246
For each of the previously published contra-indications to UKR (age <60years, weight ≥180lb, 247 heavy labour or activity, chondrocalcinosis and exposed bone in the PFJ) ten-year functional 248 outcomes were equal, or superior in those knees with contra-indications compared to those 249 knees considered ideal. Additionally for each of the contra-indications no difference in implant 250 survival at fifteen-years was seen compared to ideal candidates providing strong evidence 251 that mobile-bearing should not be restricted in these cases. 252
One of the reasons that patient selection guidelines were introduced was that, bas ed on the 253 experience with fixed-bearing UKR, it was noted that some patients groups had poor 254 outcomes [8] . One such group is young males (age<60) weighing 180lb or greater with a high 255 activity level which in this series of mobile-bearing UKR we found to have better results than 256 of knees not in this group with no difference in implant survival at fifteen-years. 257
Previous shorter term studies have also shown that patients treated with the mobile-bearing 258 UKR that have the proposed contra-indications have similar functional outcomes and survival 259 as those considered ideal [16, 17] . This study has however shown that patients with contra-260 indications actually have better results. Therefore applying the contra-indications will worsen 261 outcomes overall as UKR will not be carried out in the patients who have the potential to attain 262 best results from it. Why in this study patient with contra-indications actually had better results 263 is unclear as aside from those with high activity levels no difference in pre-operative AKSS-O 264 was seen between groups. For some patients for example those under 60 years or over 180lb 265 (who tended to be younger) this may relate to a higher potential to achieve optimum functional 266 outcomes, for others including those with PFJ disease, the improved outcomes may relate to 267 restoring the native knee kinematics. 268
The indications for the Oxford knee are based on patho-anatomy and if a patient has 269 anteromedial OA or medial osteonecrosis it is recommend that a UKR should be implanted. 270
These indications are satisfied in 50% or more cases that need knee replacement and during 271 the study period around 60% of all primary knee replacements performed were UKR. This 272 would have been reduced to under 20% if the contra-indications were used [5, 18] . Additionally, 273 further reductions in UKR utilisation would be seen if there was a requirement for focal medial 274 pain which many consider to be important, even though it has been shown to be unnecessary 275 as it does not influence the outcome [19] . If surgeons do small numbers of UKR or have UKR 276 utilisation of less than 20% data from the National Joint Registry has shown the failure rate 277 increases [20] . This further supports the recommendation that if surgeons want to use mobile-278 bearing UKR they should base their indications on the pathoanatomy and ignore the contra-279 indications proposed by Kozinn and Scott [21] [22] [23] [24] [25] [26] . 280
The strengths of this study are that it is a consecutive series with long-term, comprehensive, 281 clinical follow up. The limitations are that is that this is a designer series and the results 282 observed may not be representative, however similar results have been published at 283 independent centres at shorter follow up providing further support for using broad indications 284 for mobile-bearing UKR [22] [23] [24] [25] 27] . A further limitation is that, whilst all comparisons were 285 appropriately powered, larger subgroups of patients, with more data at longer term follow up 286 would increase the confidence in the observations made. 287
Conclusion 290
This study provides long-term evidence that for mobile-bearing UKR the indications should be 291 based on the patho-anatomy of the disease, as proposed by Goodfellow et al. and does not 292 support the contra-indications proposed by Kozinn and Scott and others [2, 3] . Indeed patients 293 with the contra-indications do better than those without. 294 
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